Clinical Trials Browser

OTHER × Lung Neoplasms × Immunotherapy, Adoptive × Clear all

NCT03525782 2018-05-16

Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms